TCFG Investment Advisors, LLC
Filing Date
Mar 31, 2026
Global Rank
#5,120
/ 8,578
Top Industry
Semiconductors
15.7%
Period ended 3 months ago
Filed May 6, 2026 · 41d
Clone Performance
May 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-2.8%
SPY
+2.1%
Annualised alpha
—
Max drawdown
−7.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
132 positions · as of Mar 31, 2026Top Position
11.4%
of portfolio value
Top 5
34.9%
of portfolio value
Top 10
47.0%
of portfolio value
HHI
363
Diversified
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 34.3% | $45,167,852 |
| Basic Materials | 15.0% | $19,727,662 |
| Financial Services | 11.2% | $14,772,064 |
| Energy | 9.3% | $12,247,700 |
| Communication Services | 6.7% | $8,878,582 |
| Consumer Cyclical | 6.1% | $8,018,964 |
| Unclassified | 5.3% | $7,026,139 |
| Industrials | 5.2% | $6,797,939 |
| Consumer Defensive | 3.5% | $4,639,044 |
| Healthcare | 2.2% | $2,951,319 |
| Utilities | 0.8% | $1,095,547 |
| Real Estate | 0.2% | $260,927 |
6 positions ·
$2,951,319 total
· Healthcare only
· as of Mar 31, 2026
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| JNJ |
Johnson & Johnson
Healthcare
|
First | 3,637 | $889,028 | 30.12% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
First | 6,902 | $830,241 | 28.13% | |
| LLY |
ELI LILLY & Co
Healthcare
|
First | 618 | $568,417 | 19.26% | |
| AMGN |
Amgen Inc
Healthcare
|
First | 935 | $328,979 | 11.15% | |
| CI |
Cigna Group
Healthcare
|
First | 813 | $216,867 | 7.35% | |
| STXS |
Stereotaxis, Inc.
Healthcare
|
First | 64,015 | $117,787 | 3.99% |